SPIRO[[1,3]DIOXOLO[4,5-G]PYRROLO[1,2-A]QUINOXALINE-4(5H),4'-PIPERIDINE], 98.0%, 250mg

(E)-3-(2-Methoxypyridin-3-yl)acrylic acid, 98%, 10g

Hexyl Acetate>99.0%(GC)25mL

(R)-3-Benzylmorpholine, 95.0%, 1g

(S)-1-(2-Chloroacetyl)-pyrrolidine-2-carbonitrile, 95.0%, 5g

(1S,5R,E)-5-(tert-butyldimethylsilyloxy)-3-((E)-2-((1R,3aS,7aR)-1-((2R,5S)-5,6-dimethylheptan-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-2-methylenecyclohexanol, 97%, 5mg

2,3,5-Triphenyltetrazolium Chloride>98.0%(T)1g

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-N-(2,4-dimethoxybenzyl)-L-alanine, 95%, 500mg

Gants de protection chimique Butoject® 897, Taille, 9, 1 paire

(S)-Tetrahydrofuran-3-amine, 97.0%, 500mg

(S)-2-AMINO-3-(ETHYL(PHENYL)AMINO)PROPAN-1-OL, 95.0%, 250mg

(2-Chloro-5-iodophenyl)(4-ethoxyphenyl)methanone, 97.0%, 5g

cis-4-Amino-tetrahydro-furan-3-carboxylic acid methyl ester hydrochloride, 98%, 100mg